CT screening of head and neck vascular injuries by emergency departments could lead to more aggressive therapies that result in improved outcomes.
CT screening of head and neck vascular injuries by emergency departments could lead to more aggressive therapies that result in improved outcomes.
Dr. Grit Rademacher and colleagues from the Unfallkrankenhaus Berlin compared findings from ultrasound exams used to screen carotid arteries for injury with the results of CT angiography scans for the same indication. The ultrasound exams were acquired over five years and the CT scans over a one-year period.
The results were dramatic, Rademacher reported at the 2005 RSNA meeting. The ultrasound scans of 1471 patients produced a sensitivity of 38.5% and a specificity of 100%. One year after installation of a multislice CT device, CTA scans performed on 407 ER patients yielded a sensitivity of 100% and a specificity of 99.1%, with one false positive.
Today the facility's protocol calls for CTA in all instances of possible carotid trauma, Rademacher said. The team now skips traditional angiography and, after one year of experience, is confident that all injuries can be caught in the first scan.
Four Strategies to Address the Tipping Point in Radiology
January 17th 2025In order to flip the script on the impact of the radiology workforce shortage, radiology groups and practices need to make sound investments in technologies and leverage partnerships to mitigate gaps in coverage and maximize workflow efficiencies.
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI-Based AI Enhance Risk Stratification in Prostate Cancer?
January 13th 2025Employing baseline MRI and clinical data, an emerging deep learning model was 32 percent more likely to predict the progression of low-risk prostate cancer (PCa) to clinically significant prostate cancer (csPCa), according to new research.